A dozen leading pharmaceutical companies have paid doctors in the US more than $150m so far this year, according to data that will intensify scrutiny over the lack of transparency around hotly debated marketing and support practices.
via ft.com
A dozen leading pharmaceutical companies have paid doctors in the US more than $150m so far this year, according to data that will intensify scrutiny over the lack of transparency around hotly debated marketing and support practices.
No comments:
Post a Comment